These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15661156)

  • 1. Myxoma virus infection of primary human fibroblasts varies with cellular age and is regulated by host interferon responses.
    Johnston JB; Nazarian SH; Natale R; McFadden G
    Virology; 2005 Feb; 332(1):235-48. PubMed ID: 15661156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxoma virus selectively disrupts type I interferon signaling in primary human fibroblasts by blocking the activation of the Janus kinase Tyk2.
    Wang F; Barrett JW; Shao Q; Gao X; Dekaban GA; McFadden G
    Virology; 2009 Apr; 387(1):136-46. PubMed ID: 19254804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts.
    Bartee E; Mohamed MR; Lopez MC; Baker HV; McFadden G
    J Virol; 2009 Jan; 83(2):498-511. PubMed ID: 18971273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
    Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
    J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxoma virus M063R is a host range gene essential for virus replication in rabbit cells.
    Barrett JW; Shun Chang C; Wang G; Werden SJ; Shao Z; Barrett C; Gao X; Belsito TA; Villenevue D; McFadden G
    Virology; 2007 Apr; 361(1):123-32. PubMed ID: 17184804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of pseudorabies virus replication by porcine alpha/beta interferon and gamma interferon in vitro.
    Yao Q; Qian P; Cao Y; He Y; Si Y; Xu Z; Chen H
    Eur Cytokine Netw; 2007 Jun; 18(2):71-7. PubMed ID: 17594939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
    Trottier MD; Palian BM; Reiss CS
    Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational control of the innate immune response through IRF-7.
    Colina R; Costa-Mattioli M; Dowling RJ; Jaramillo M; Tai LH; Breitbach CJ; Martineau Y; Larsson O; Rong L; Svitkin YV; Makrigiannis AP; Bell JC; Sonenberg N
    Nature; 2008 Mar; 452(7185):323-8. PubMed ID: 18272964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth sensitivity of a recombinant simian virus 5 P/V mutant to type I interferon differs between tumor cell lines and normal primary cells.
    Wansley EK; Dillon PJ; Gainey MD; Tam J; Cramer SD; Parks GD
    Virology; 2005 Apr; 335(1):131-44. PubMed ID: 15823612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M-T5, the ankyrin repeat, host range protein of myxoma virus, activates Akt and can be functionally replaced by cellular PIKE-A.
    Werden SJ; Barrett JW; Wang G; Stanford MM; McFadden G
    J Virol; 2007 Mar; 81(5):2340-8. PubMed ID: 17151107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xiao chai hu tang inhibits CVB1 virus infection of CCFS-1 cells through the induction of Type I interferon expression.
    Cheng PW; Ng LT; Lin CC
    Int Immunopharmacol; 2006 Jun; 6(6):1003-12. PubMed ID: 16644487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts.
    Douagi I; McInerney GM; Hidmark AS; Miriallis V; Johansen K; Svensson L; Karlsson Hedestam GB
    J Virol; 2007 Mar; 81(6):2758-68. PubMed ID: 17215281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poxvirus host range genes.
    Werden SJ; Rahman MM; McFadden G
    Adv Virus Res; 2008; 71():135-71. PubMed ID: 18585528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages.
    Wang F; Gao X; Barrett JW; Shao Q; Bartee E; Mohamed MR; Rahman M; Werden S; Irvine T; Cao J; Dekaban GA; McFadden G
    PLoS Pathog; 2008 Jul; 4(7):e1000099. PubMed ID: 18617992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
    Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A
    Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial patterns of protein expression in focal infections of human cytomegalovirus.
    Lam V; Boehme KW; Compton T; Yin J
    Biotechnol Bioeng; 2006 Apr; 93(6):1029-39. PubMed ID: 16506244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.
    Lefort S; Soucy-Faulkner A; Grandvaux N; Flamand L
    J Virol; 2007 Oct; 81(20):10950-60. PubMed ID: 17652396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses.
    Fink K; Lang KS; Manjarrez-Orduno N; Junt T; Senn BM; Holdener M; Akira S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2006 Aug; 36(8):2094-105. PubMed ID: 16810635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3.
    Hato SV; Ricour C; Schulte BM; Lanke KH; de Bruijni M; Zoll J; Melchers WJ; Michiels T; van Kuppeveld FJ
    Cell Microbiol; 2007 Dec; 9(12):2921-30. PubMed ID: 17991048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct signature type I interferon responses are determined by the infecting virus and the target cell.
    Baig E; Fish EN
    Antivir Ther; 2008; 13(3):409-22. PubMed ID: 18572754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.